Published by at November 1, 2026 The FDA should create an expedited pathway for clinical tests targeting emerging drug threats, write Dr. Shravani Durbhakula and Jeremy Kourvelas. November 1, 2026 https://time.com/article/2026/11/01/why-doctors-are-last-to-know-what-s-in-the-drug-supply/